We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
PUT
Cardinal Health
CAH
$53.4B
| $504K | ﹤0.01% |
+3,000
| New | +$445K |
|
|
PPL
902
PPL Corp
PPL
$27.3B
| $498K | ﹤0.01% |
14,689
+4,529
| +45% | +$158K |
|
|
TACOW
903
Berto Acquisition Corp Warrant
TACOW
$16.6M
| $497K | ﹤0.01% |
+625,000
| New | +$468K |
|
904
CALL
Marriott International
MAR
$98.7B
| $492K | ﹤0.01% |
+1,800
| New | +$451K |
|
905
PUT
Cardiff Oncology
CRDF
$64.3M
| $488K | ﹤0.01% |
155,000
+30,000
| +24% | +$91.5K |
|
|
GSRTR
906
DELISTED
GSR III Acquisition Corp Right
GSRTR
| $488K | ﹤0.01% |
71,402
-71,168
| -50% | -$266K |
|
907
Southwest Airlines
LUV
$22.1B
| $486K | ﹤0.01% |
+14,996
| New | +$452K |
|
908
PUT
United Airlines
UAL
$38.4B
| $486K | ﹤0.01% |
+6,100
| New | +$449K |
|
909
CALL
HP
HPQ
$23.5B
| $484K | ﹤0.01% |
+19,800
| New | +$505K |
|
910
Altria Group
MO
$122B
| $484K | ﹤0.01% |
8,253
+7,481
| +969% | +$439K |
|
911
NRG Energy
NRG
$29.8B
| $482K | ﹤0.01% |
+3,000
| New | +$395K |
|
912
CMS Energy
CMS
$23.1B
| $478K | ﹤0.01% |
6,906
+1,852
| +37% | +$132K |
|
913
CALL
CSX Corp
CSX
$98.6B
| $476K | ﹤0.01% |
+14,600
| New | +$439K |
|
914
Playtika
PLTK
$1.4B
| $473K | ﹤0.01% |
100,000
| – | – |
|
915
CALL
Palo Alto Networks
PANW
$264B
| $471K | ﹤0.01% |
+2,300
| New | +$427K |
|
916
Bio-Rad Laboratories Class A
BIO
$8.42B
| $470K | ﹤0.01% |
+1,948
| New | +$460K |
|
917
Baker Hughes
BKR
$56.8B
| $468K | ﹤0.01% |
12,218
+11,527
| +1,668% | +$435K |
|
918
CALL
GE HealthCare
GEHC
$27.6B
| $467K | ﹤0.01% |
+6,300
| New | +$439K |
|
|
919
PUT
GE HealthCare
GEHC
$27.6B
| $467K | ﹤0.01% |
+6,300
| New | +$439K |
|
920
Replimune Group
REPL
$814M
| $465K | ﹤0.01% |
+50,000
| New | +$436K |
|
921
PUT
PepsiCo
PEP
$186B
| $462K | ﹤0.01% |
3,500
-13,100
| -79% | -$1.76M |
|
922
Palladyne AI Corp Warrants
PDYNW
$295K
| $456K | ﹤0.01% |
1,198,387
| – | – |
|
923
PUT
Rio Tinto
RIO
$148B
| $455K | ﹤0.01% |
7,800
-4,800
| -38% | -$283K |
|
924
PUT
Newmont
NEM
$98.2B
| $454K | ﹤0.01% |
+7,800
| New | +$416K |
|
925
CALL
Kenvue
KVUE
$37B
| $454K | ﹤0.01% |
+21,700
| New | +$494K |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.